Cerevel Therapeutics
CERE
#1975
Rank
€7.39 B
Marketcap
40,57 €
Share price
0.00%
Change (1 day)
107.98%
Change (1 year)

EPS for Cerevel Therapeutics (CERE)

EPS in 2023 (TTM): -2,32 €

According to Cerevel Therapeutics's latest financial reports the company's current EPS (TTM) is -2,26 €. In 2022 the company made an earnings per share (EPS) of -2,09 € a decrease over its 2021 EPS that were of -1,49 €.

EPS history for Cerevel Therapeutics from 2020 to 2023

Annual EPS

Year EPS Change
2023 (TTM)-2,32 €10.83%
2022-2,09 €40.61%
2021-1,49 €36.84%
2020-1,09 €

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
6,51 €-388.52%🇺🇸 USA
1,66 €-173.60%🇺🇸 USA
8,74 €-487.60%🇺🇸 USA
2,60 €-215.20%🇺🇸 USA